860
Participants
Start Date
December 14, 2016
Primary Completion Date
July 31, 2018
Study Completion Date
August 7, 2018
Delafloxacin
Antibacterial agent, 300 mg IV, Q12H for at least 6 doses with potential to switch to 450 mg oral tablet, Q12H for up to 20 doses total
Moxifloxacin
Antibacterial Agent, 400 mg IV, Q24H for at least 3 doses with potential to switch to 400 mg oral over-encapsulated tablet, Q24H for up to 10 doses total
Linezolid
Antibacterial Agent, at local investigator discretion, subjects in the moxifloxacin arm with confirmed MRSA can switch to linezolid 600 mg IV Q12H for all remaining doses
Melinta 306 Study Site, Buffalo
Melinta 306 Study Site, Newark
Melinta 306 Study Site, Baltimore
Melinta 306 Study Site, Charlotte
Melinta 306 Study Site, DeBary
Melinta 306 Study Site, DeLand
Melinta 306 Study Site, Miami
Melinta 306 Study Site, Coral Gables
Melinta 306 Study Site, Miami
Melinta 306 Study Site, Fort Myers
Melinta 306 Study Site, Montgomery
Melinta 306 Study Site, Franklin
Melinta 306 Study Site, Louisville
Melinta 306 Study Site, Dayton
Melinta 306 Study Site, Saint Paul
Melinta 306 Study Site, Rapid City
Melinta 306 Study Site, Butte
Melinta 306 Study Site, St Louis
Melinta 306 Study Site, Omaha
Melinta 306 Study Site, Corsicana
Melinta 306 Study Site, Natchitoches
Melinta 306 Study Site, Boston
Melinta 306 Study Site, Burlington
Melinta 306 Study Site, Newark
Melinta 306 Study Site, Cleveland
Melinta 306 Study Site, Buenos Aires
Melinta 306 Study Site, Córdoba
Melinta 306 Study Site, La Plata
Melinta 306 Study Site, Pleven
Melinta 306 Study Site, Rousse
Melinta 306 Study Site, Sofia
Melinta 306 Study Site, Stara Zagora
Melinta 306 Study Site, Barranquilla
Melinta 306 Study Site, Manizales
Melinta 306 Study Site, Medellín
Melinta 306 Study Site, Quindío
Melinta 306 Study Site, Santiago de Cali
Melinta 306 Study Site, Santo Domingo
Melinta 306 Study Site, Tbilisi
Melinta 306 Study Site, Leverkusen
Melinta 306 Study Site, Munich
Melinta 306 Study Site, Budapest
Melinta 306 Study Site, Debrecen
Melinta 306 Study Site, Deszk
Melinta 306 Study Site, Miskolc
Melinta 306 Study Site, Nyíregyháza
Melinta 306 Study Site, Szombathely
Melinta 306 Study Site, Daugavpils
Melinta 306 Study Site, Liepāja
Melinta 306 Study Site, Riga
Melinta 306 Study Site, Lima
Melinta 306 Study Site, Chrzanów
Melinta 306 Study Site, Katowice
Melinta 306 Study Site, Lodz
Melinta 306 Study Site, Wroclaw
Melinta 306 Study Site, Brasov
Melinta 306 Study Site, Bucharest
Melinta 306 Study Site, Craiova
Melinta 306 Study Site, Timișoara
Melinta 306 Study Site, Arkhangelsk
Melinta 306 Study Site, Moscow
Melinta 306 Study Site, Saint Petersburg
Melinta 306 Study Site, Smolensk
Melinta 306 Study Site, Vsevolozhsk
Melinta 306 Study Site, Belgrade
Melinta 306 Study Site, Kamenitz
Melinta 306 Study Site, Kragujevac
Melinta 306 Study Site, Niš
Melinta 306 Study Site, Golnik
Melinta 306 Study Site, Ljubljana
Melinta 306 Study Site, Benoni
Melinta 306 Study Site, Chatsworth
Melinta 306 Study Site, Krugersdorp
Melinta 306 Study Site, Middelburg
Melinta 306 Study Site, Phoenix
Melinta 306 Study Site, Port Elizabeth
Melinta 306 Study Site, Pretoria
Melinta 306 Study Site, Worcester
Melinta 306 Study Site, Badalona
Melinta 306 Study Site, Barcelona
Melinta 306 Study Site, Madrid
Melinta 306 Study Site, Terrassa
Melinta 306 Study Site, Valencia
Melinta 306 Study Site, Dnipro
Melinta 306 Study Site, Kharkiv
Melinta 306 Study Site, Kyiv
Melinta 306 Study Site, Poltava
Melinta 306 Study Site, Vinnytsia
Melinta 306 Study Site, Zaporizhia
Melinta 306 Study Site, Zhytomyr
Lead Sponsor
Melinta Therapeutics, Inc.
INDUSTRY